Duality Advisers’s Usana Health Sciences USNA Stock Holding History

Duality Advisers’s Portfolio USNA Stock Details USNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-4,065	Closed	-$256K	–	742
2023 Q1	$256K	Sell	4,065 -14	-0.3%	-$835	0.03%	495
2022 Q4	$217K	Sell	4,079 -922	-18%	-$49.9K	0.02%	549
2022 Q3	$280K	Sell	5,001 -2,822	-36%	-$187K	0.03%	466
2022 Q2	$566K	Buy	+7,823	New	+$583K	0.06%	443
2021 Q4	–	Sell	-6,949	Closed	-$641K	–	692
2021 Q3	$641K	Sell	6,949 -1,949	-22%	-$188K	0.05%	412
2021 Q2	$911K	Sell	8,898 -1,179	-12%	-$118K	0.08%	344
2021 Q1	$984K	Sell	10,077 -783	-7%	-$71.3K	0.09%	348
2020 Q4	$837K	Buy	+10,860	New	+$840K	0.06%	381

Other funds holding USNA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Duality Advisers's USNA Position: Q2 2023 in Review

Duality Advisers sold out of Usana Health Sciences (USNA) in Q2 2023, closing a stake of 4,065 shares — an estimated $256K sold.

Duality Advisers first reported a position in USNA in Q4 2020 and held it in 8 quarters. The position peaked at $984K in Q1 2021. 169 funds tracked by Wall St. Rank hold USNA as of Q2 2023.

Duality Advisers reported no remaining Usana Health Sciences position as of Q2 2023 after selling out during the quarter.
Duality Advisers sold 4,065 Usana Health Sciences shares in Q2 2023, an estimated $256K.
Duality Advisers first reported a position in Usana Health Sciences in Q4 2020 and held it in 8 quarters.
Duality Advisers's Usana Health Sciences position peaked at $984K in Q1 2021.
169 funds tracked by Wall St. Rank held Usana Health Sciences as of Q2 2023.

Based on Duality Advisers's 13F filing for Q2 2023, filed 31 Jul 2023.